Lenox Wealth Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-96
Closed -$5K 783
2021
Q2
$5K Hold
96
﹤0.01% 562
2021
Q1
$5K Hold
96
﹤0.01% 513
2020
Q4
$5K Sell
96
-161
-63% -$7.94K ﹤0.01% 511
2020
Q3
$13K Buy
257
+161
+168% +$8.29K ﹤0.01% 348
2020
Q2
$5K Hold
96
﹤0.01% 437
2020
Q1
$4K Hold
96
﹤0.01% 462
2019
Q4
$5K Hold
96
﹤0.01% 487
2019
Q3
$4K Hold
96
﹤0.01% 427
2019
Q2
$4K Buy
96
+22
+30% +$936 ﹤0.01% 337
2019
Q1
$3K Hold
74
﹤0.01% 483
2018
Q4
$3K Hold
74
﹤0.01% 324
2018
Q3
$3K Sell
74
-694
-90% -$29.6K ﹤0.01% 344
2018
Q2
$31K Sell
768
-2,408
-76% -$94.8K 0.01% 189
2018
Q1
$127K Buy
+3,176
New +$132K 0.03% 89
2013
Q3
Sell
-180
Closed -$9K 287
2013
Q2
$9K Buy
+180
New +$9.59K 0.01% 122

Other funds holding SNY

Lenox Wealth Advisors's SNY Position: Q3 2021 in Review

Lenox Wealth Advisors sold out of Sanofi (SNY) in Q3 2021, closing a stake of 96 shares — an estimated $5K sold.

Lenox Wealth Advisors first reported a position in SNY in Q2 2013 and held it in 15 quarters. The position peaked at $127K in Q1 2018. 577 funds tracked by Wall St. Rank hold SNY as of Q3 2021.

  • Lenox Wealth Advisors reported no remaining Sanofi position as of Q3 2021 after selling out during the quarter.
  • Lenox Wealth Advisors sold 96 Sanofi shares in Q3 2021, an estimated $5K.
  • Lenox Wealth Advisors first reported a position in Sanofi in Q2 2013 and held it in 15 quarters.
  • Lenox Wealth Advisors's Sanofi position peaked at $127K in Q1 2018.
  • 577 funds tracked by Wall St. Rank held Sanofi as of Q3 2021.

Based on Lenox Wealth Advisors's 13F filing for Q3 2021, filed 12 Oct 2021.